Search research articles
Contact Us
Filters
Showing results (221-230 of 245) with videos related to
Page
of 25
Sort By:
Archivos De La Sociedad Espanola De Oftalmologia
|
July 1, 2020
Effects and safety of perfluorohexyloctane on the eye surface and corneal endothelium
A J Mateo Orobia, A Blasco-Martinez, P Rodríguez-Ausín, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism
C Rubio-Terrés, J M Soria, P E Morange, et al.
British Journal of Cancer
|
October 15, 2014
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
D Lorente, A Omlin, R Ferraldeschi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 5, 2008
Cervical necrotizing fasciitis: 8-years' experience of microbiology
V Fihman, L Raskine, F Petitpas, et al.
BMC Ophthalmology
|
September 1, 2025
Identification of tear lipid biomarkers in women with dry eye disease and the impact of intense pulsed light therapy: a case-control study
Arantxa Acera, Oliver Ibarrondo, Antonio J Mateo-Orobia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2017
Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone
C Massard, J Mateo, Y Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2018
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts
D Lorente, D Olmos, J Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2025
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
C Valenza, E F Saldanha, Y Gong, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 15, 2012
Clinicopathological risk factors of Stage II colon cancer: results of a prospective study
C Santos, A López-Doriga, M Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 245) with videos related to
Sort By:
Page
of 25
Archivos De La Sociedad Espanola De Oftalmologia
|
July 1, 2020
Effects and safety of perfluorohexyloctane on the eye surface and corneal endothelium
A J Mateo Orobia, A Blasco-Martinez, P Rodríguez-Ausín, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
Economic Analysis Of Thrombo Incode, A Clinical-Genetic Function For Assessing The Risk Of Venous Thromboembolism
C Rubio-Terrés, J M Soria, P E Morange, et al.
British Journal of Cancer
|
October 15, 2014
Tumour responses following a steroid switch from prednisone to dexamethasone in castration-resistant prostate cancer patients progressing on abiraterone
D Lorente, A Omlin, R Ferraldeschi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
March 5, 2008
Cervical necrotizing fasciitis: 8-years' experience of microbiology
V Fihman, L Raskine, F Petitpas, et al.
BMC Ophthalmology
|
September 1, 2025
Identification of tear lipid biomarkers in women with dry eye disease and the impact of intense pulsed light therapy: a case-control study
Arantxa Acera, Oliver Ibarrondo, Antonio J Mateo-Orobia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2017
Phase I/II trial of cabazitaxel plus abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) progressing after docetaxel and abiraterone
C Massard, J Mateo, Y Loriot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 10, 2018
Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts
D Lorente, D Olmos, J Mateo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2025
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
C Valenza, E F Saldanha, Y Gong, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 15, 2012
Clinicopathological risk factors of Stage II colon cancer: results of a prospective study
C Santos, A López-Doriga, M Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2018
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)
J Mateo, D Chakravarty, R Dienstmann, et al.
Page
of 25